Back to top

Image: Bigstock

Top Ranked Value Stocks to Buy for December 4th

Read MoreHide Full Article

 

Here are four stocks with buy rank and strong value characteristics for investors to consider today, December 4th:

Stifel Financial Corp. (SF - Free Report) : This financial services and bank holding company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings rising 1.8% over the last 60 days.

Stifel Financial Corporation Price and Consensus

Stifel Financialhas a price-to-earnings ratio (P/E) of 16.85, compared with 45.30 for the industry. The company possesses a Value Scoreof B.

Stifel Financial Corporation PE Ratio (TTM)

Huntsman Corporation (HUN - Free Report) : This manufacturer of organic and inorganic chemical products, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 19.5% over the last 60 days.

Huntsman Corporation Price and Consensus

Huntsman has a price-to-earnings ratio (P/E) of 11.77, compared with 18.90 for the industry. The company possesses a Value Score of A.

Huntsman Corporation PE Ratio (TTM)

Lazard Ltd. (LAZ - Free Report) : This intellectual property licensing company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings advancing 2.6% over the last 60 days.

Lazard Ltd. Price and Consensus

Lazard has a price-to-earnings ratio (P/E) of 13.99, compared with 16.20 for the industry. The company possesses a Value Score of A.

Lazard Ltd. PE Ratio (TTM)

Tyson Foods, Inc. (TSN - Free Report) : This global food company has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 5.4% over the last 60 days.

Tyson Foods, Inc. Price and Consensus

Tyson Foods has a price-to-earnings ratio (P/E) of 14.18, compared with 16.50 for the industry. The company possesses a Value Score of A.

Tyson Foods, Inc. PE Ratio (TTM)

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>